In a move that’s unlikely to curry much favor with House progressives, the White House has reaffirmed its commitment to a long-standing deal it made with the pharmaceutical industry, that will require them to cover, through industry reforms, no more than $80 billion worth of what’s expected to be the approximately $1 trillion cost of health care reform.
This is a companion discussion topic for the original entry at https://talkingpointsmemo.com/?p=139814